We're translating the genetic language of the adaptive immune system into products that can diagnose and treat disease. When we started in 2009, my brother Harlan and I saw that if we could actually read how the immune system detects and fights illness, we could harness that natural power to help people. The adaptive immune system is incredibly sophisticated - it's identifying and addressing disease before you even feel sick. We've spent over a decade building our proprietary platform to decode these immune signals at scale.
Today, we're applying what we've learned across three areas: life sciences research, clinical diagnostics, and drug discovery. Our clonoSEQ test helps doctors detect minimal residual disease in blood cancer patients with remarkable precision. And through our Immune Medicine Platform, we're using advances in computational biology and machine learning to turn vast systems of biology into actionable data. The goal is simple but ambitious: use the wisdom inside each person's immune system to transform how medicine detects and treats disease.
